Pyrimidyl indoline compound
US8232287B2 · kind B2 · utility
3Cited by
4References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2008 |
| Grant date | Jul 31, 2012 |
| Priority date | — |
| Expiry date | Nov 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is intended to provide a pyrimidyl indoline compound which structurally differs from compounds used as active ingredients in conventional oral hypoglycemic agents and has excellent hypoglycemic effect. The present invention provides a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.